Scott Antonia : Peregrine Pharmaceuticals KOL : March 7, 2015
... don't forget, tomorrow is not just a normal Saturday. A Saturday of HOPE for all lung cancer patients in learning all that David Carbone and Scott Antonia will talk about (both Peregrine Key Opinion Leaders)
Its going to be a webcast to listen if you can not attend
-------------
HOPE Summit Live: Living Well with Lung Cancer
Date/Time: 03/07/2015 09:30 AM - 03/07/2015 02:30 PM Type: Education Location: Ted and Marty Couch Auditorium, Moffitt Cancer Center
Education, Empowerment and Learning from Others with Lung Cancer
Please join us in person for this FREE interactive summit to learn:
Faculty presenters to include:
David Carbone, MD, PhD The Ohio State University-James Cancer Hospital and Solove Research Institute Scott J. Antonia, MD, PhD Moffitt Cancer Center
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!